- PLN19.10m
- PLN16.24m
- PLN2.34m
Brief: Genxone Signs Up To EUR 195,500 Deal With gMendel
Brief: Genxone AGM To Vote On Allocating 2022 Net Profit To Supplementary Capital
Brief: genXone Q1 Net Result Turns To Loss Of 0.8 Mln Zlotys
Brief: Genxone Signs 9.0 Mln Zloty Deal With Human Biome Institute
Brief: Genxone FY Net Profit Down At 0.5 Mln Zlotys
Brief: Genxone Files Motion To Polish National R&D Center To End Works On Project Regarding Post-Surgical Wounds Diagnostics
Brief: Genxone Signs Letter Of Intent With gMendel ApS
Brief: Genxone Signs Deal With Olsztyn's Sanitary And Epidemiological Office Following Being Chosen In Tender
Brief: Genxone 0.2 Mln Zloty Offer Chosen In Tender By Olsztyn's Sanitary And Epidemiological Office
Brief: Genxone Signs Estimated 0.1 Mln Zloty Deal With Pure Clinical
Brief: Genxone Starts Sale Of Nanobiome Tests
Brief: Genxone Signs 0.4 Mln Zloty Net Deal With Epidemiological Station In Olsztyn
Brief: Diagnostyka Ups Stake In Genxone To 38.61%
Brief: Torox EKO FIZAN Fund Divests Its 14.29% Stake in Genxone
Brief: Genxone Signs Deal For 1.0 Mln Zlotys Gross
Brief: Genxone Management Will Recommend AGM 2020 Dividend Of 0.65 Zloty/Shr
Brief: Genxone Signs Validation Deal For New PCR SARS-CoV-2 Test With South Korean Seegene
Brief: Genxone Signs Deal For Genome Sequencing Of COVID-19
Brief: Torox Eko Fizan Fund Lowers Stake In Genxone To 14.96%